SND-209

N/A

Report date: 2025/01/23 11:41:27

NME

Base Information

Drug NameSND-209

Drug Alias NameSND-209SND209

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase 9 modulators

TargetsMatrix metalloproteinase 9

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFloratek Pharma

China Registration ClassN/A

Active CompaniesFloratek Pharma

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A